ESC 365 - Should all menopausal women be prescribed hormone replacement therapy to reduce risk? - discussion

ESC Professional Premium Access

Should all menopausal women be prescribed hormone replacement therapy to reduce risk? - discussion

Session: Great Debate: should all menopausal women be prescribed hormone replacement therapy to reduce risk?

Topic: Cardiovascular Disease in Women

Event: ESC Congress 2024

Congress Presentation

Add to my library

2 more presentations in this session

Should all menopausal women be prescribed hormone replacement therapy to reduce risk? - pro

Speaker: Associate Professor C. Gebhard (Bern, CH)

Should all menopausal women be prescribed hormone replacement therapy to reduce risk? - con

Speaker: Professor M. Gulati (Los Angeles, US)

Access the full session

Great Debate: should all menopausal women be prescribed hormone replacement therapy to reduce risk?

Speakers: Associate Professor C. Gebhard, Professor M. Gulati

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources